Comparisons between tumor burden and other prognostic factors that influence survival of patients with non‐small cell lung cancer treated with immune checkpoint inhibitors

BACKGROUND: The use of baseline tumor burden (TB) as a prognostic factor for non‐small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs) and associations between TB and other prognostic biomarkers remain unclear. In this study, we investigated the association between...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakata, Yoshihiko, Kawamura, Kodai, Ichikado, Kazuya, Shingu, Naoki, Yasuda, Yuko, Eguchi, Yoshitomo, Hisanaga, Jumpei, Nitawaki, Tatsuya, Iio, Miwa, Sekido, Yuko, Nakano, Aiko, Sakagami, Takuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885438/
https://www.ncbi.nlm.nih.gov/pubmed/31679185
http://dx.doi.org/10.1111/1759-7714.13214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885438/
https://www.ncbi.nlm.nih.gov/pubmed/31679185
http://dx.doi.org/10.1111/1759-7714.13214

Ejemplares similares